ALEXANDRA KITCHENER: Open Payments
NPI 1629616552 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,506 in 74 payments from 17 companies in 2025. Trend: 2023 $1,099 · 2024 $1,521 · 2025 $1,506
Food & beverage: $1,506
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $236 |
| SCPHARMACEUTICALS INC. | 13 | $192 |
| Esperion Therapeutics, Inc. | 11 | $176 |
| Amgen Inc. | 11 | $135 |
| Abbott Laboratories | 1 | $118 |
| CVRx, Inc. | 4 | $115 |
| PFIZER INC. | 5 | $108 |
| Novartis Pharmaceuticals Corporation | 5 | $98 |
| BridgeBio Pharma, Inc. | 3 | $71 |
| Merck Sharp & Dohme LLC | 3 | $64 |
Products named: Kerendia, FUROSCIX, NEXLETOL, REPATHA, AVEIR, Barostim Neo System, ELIQUIS, LEQVIO.
Industry payments across FL — which companies pay providers there.
